Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Tax treatment influences index fund performance in IRAs. This guide breaks down how Roth and traditional IRAs compare in real‑world scenarios.
28,321 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Bitcoin hovers around $70,000 after a brief pullback, as volatility eases and traders weigh whether this is the momen...
A small-cap value ETF built years of academic research is beating the S&P 500 in early 2026, buoyed by a strict value...
The May inflation report released this morning jolted trading desks and left investors weighing the Federal Reserve’s...
Lawmakers push a roadmap for crypto regulation with an April vote and a May passage deadline. This article breaks dow...
A KRW-backed stablecoin and offshore perpetual futures contract launch in April 2026, signaling Wall Street’s push to...
Two popular bond funds target different corners of the fixed-income market. This guide breaks down how Vanguard Long-...
Securitize begins trading on the NYSE under ticker SECZ following a merger, catapulting tokenization infrastructure i...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
Investors are weighing XRP and Dogecoin as potential additions to a volatile portfolio. This guide breaks down risk, ...
A regional bank melt-up: this market moment could offer outsized gains, but it comes with sharp risks. Learn how to e...